A newly modified CART neuropeptide has demonstrated remarkable stability, appetite reduction, and brain protection against harmful tau proteins linked to Alzheimer’s disease. This breakthrough research, recently published in the European Journal of Pharmacology, has shown promising results in both cellular and animal tests.
In experiments, the modified compound led to significant weight loss in higher-weight mice and reduced the presence of tau protein in their brains—a key marker associated with Alzheimer’s. The success of this compound lies in its modification with fatty acids, which enhance its ability to cross the blood-brain barrier. This improved delivery allows the neuropeptide to effectively reduce appetite and offer neuroprotective benefits, making it a potential candidate for treating or preventing neurodegenerative diseases, according to researcher Vilém Charvát.
Continue reading… “Novel CART Neuropeptide Shows Promise in Weight Loss and Alzheimer’s Protection”